LEE GARY K. (Chief Scientific Officer) sold 0.7% of their position (131.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $1.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/11/2026ACC: 0001907345-26-000004
Officer· Chief Scientific Officer
Since Jan 2022
-131.00
Net shares
Net seller
$1.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
131.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−131.00
Price / share
$14.34
Trade value
$1.88K
% of position
0.7%
8/10/2026
17.81K→17.68K
Total
Net shares
−131.00
Net value
-$1.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | S · Sale | −131.00 | $14.34 | $1.88K | 0.7% | 17.81K | 17.68K |
| Total | −131.00 | -$1.88K | ||||||
Derivative Transactions0
No derivative transactions reported